medicare-negotiation
3 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 25-799 | Boehringer Ingelheim Pharmaceuticals, Inc. v. Department of Health and Human Services, et al. | Second Circuit | 2026-01-07 | Pending | Amici (1) | due-process economic-coercion fifth-amendment first-amendment medicare-negotiation property-rights | 1. Is the Program immune from scrutiny under the First and Fifth Amendments because it relies on economic coercion to secure participation? 2. Does t… |
| 25-749 | Janssen Pharmaceuticals, Inc. v. Robert F. Kennedy, Secretary of Health and Human Services, et al. | Third Circuit | 2025-12-23 | Pending | drug-pricing economic-coercion fifth-amendment first-amendment government-compulsion medicare-negotiation | 1. Does the Program violate the First Amendment by compelling Janssen to express the Government's disputed messages regarding drug pricing? 2. Does t… | |
| 25-751 | Bristol Myers Squibb Company v. Robert F. Kennedy, Secretary of Health and Human Services, et al. | Third Circuit | 2025-12-23 | Pending | Amici (1) | constitutional-rights drug-pricing first-amendment government-compulsion medicare-negotiation takings-clause | As part of the Inflation Reduction Act of 2022, Congress created the "Medicare Drug Price Negotiation Program." Under the Program, manufacturers of th… |